Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)

SHA:605016 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	621.69	501.7	286.84	175.87	191.69	305.24
Trading Asset Securities	30.77	20.09	152.27	252.7	330	248.35
Cash & Short-Term Investments	652.46	521.8	439.11	428.57	521.69	553.59
Cash Growth	5.11%	18.83%	2.46%	-17.85%	-5.76%	291.63%
Accounts Receivable	297.6	295.18	231.44	169.43	152.63	143.62
Other Receivables	4.94	16.37	9.46	4.85	2.21	1.45
Receivables	302.54	311.55	240.9	174.27	154.83	145.07
Inventory	326.6	287.39	186.83	152.05	167.71	121.82
Prepaid Expenses	-	0.71	0.62	0	0.11	-
Other Current Assets	40.02	13.72	34	18.84	11.19	11.41
Total Current Assets	1,322	1,135	901.46	773.74	855.54	831.89
Property, Plant & Equipment	1,372	1,178	987.82	854.02	500.99	370.5
Long-Term Investments	61.95	61.95	60.88	58.98	58.9	57.17
Other Intangible Assets	18.83	16.35	17.58	14.19	14.74	15.31
Long-Term Deferred Tax Assets	11.64	7.83	6.74	2.39	2.58	2.57
Long-Term Deferred Charges	12.03	14.65	12.14	2.42	1.23	1.78
Other Long-Term Assets	65.63	22.94	26.88	48.45	37.96	3.29
Total Assets	2,863	2,437	2,014	1,754	1,472	1,283

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	195.55	169.39	242.81	214.89	93.34	46.05
Accrued Expenses	7.46	24.94	27.88	15.83	17.11	13.49
Short-Term Debt	306.18	138.99	10	-	-	1
Current Portion of Long-Term Debt	12.3	4.15	-	-	-	-
Current Portion of Leases	-	2.05	1.18	1.03	1.1	0.74
Current Income Taxes Payable	20.51	17.72	16.54	6.9	5.33	2.9
Current Unearned Revenue	3.93	4.52	3.51	2.89	4.07	6.89
Other Current Liabilities	22.34	2.02	0.53	0.15	0.15	0.15
Total Current Liabilities	568.28	363.78	302.45	241.7	121.11	71.21
Long-Term Debt	130.7	79.06	-	-	-	-
Long-Term Leases	8.09	0.94	1.02	0.63	0.35	0.78
Long-Term Unearned Revenue	50.32	28.35	27.92	1.41	2.97	4.76
Long-Term Deferred Tax Liabilities	3.03	3.06	2.89	2.62	2.58	2.31
Total Liabilities	760.41	475.19	334.27	246.35	127.01	79.05

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	420.01	420.01	323.09	248.53	177.52	126.8
Additional Paid-In Capital	337.31	337.31	434.23	508.79	579.8	630.52
Retained Earnings	1,328	1,187	905.7	735.91	573.09	433.08
Comprehensive Income & Other	17.13	17.13	16.22	14.6	14.54	13.06
Shareholders' Equity	2,103	1,961	1,679	1,508	1,345	1,203
Total Liabilities & Equity	2,863	2,437	2,014	1,754	1,472	1,283

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	457.27	225.2	12.2	1.66	1.45	2.52
Net Cash (Debt)	195.19	296.59	426.91	426.91	520.24	551.07
Net Cash Growth	-37.81%	-30.53%	-0.00%	-17.94%	-5.59%	656.39%
Net Cash Per Share	0.47	0.71	1.01	1.02	1.25	1.43
Filing Date Shares Outstanding	426.73	420.01	420.01	420.01	420.01	420.01
Total Common Shares Outstanding	426.73	420.01	420.01	420.01	420.01	420.01
Working Capital	753.34	771.38	599.01	532.04	734.43	760.68
Book Value Per Share	4.93	4.67	4.00	3.59	3.20	2.87
Tangible Book Value	2,084	1,945	1,662	1,494	1,330	1,188
Tangible Book Value Per Share	4.88	4.63	3.96	3.56	3.17	2.83
Land	-	40.41	34.94	-	-	-
Buildings	-	497.58	477.49	180.6	158.6	162.18
Machinery	-	873.24	820.77	433.86	417.39	415.03
Construction In Progress	-	209.01	10.29	522.23	193.36	17.12

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error